肠道微生物组和骨关节炎
Wiktoria Maria Krupka1,2, Gabriela Motyl1,2, Joanna Dmowska-Chalaba3
1Medical University of Warsaw, Poland.
Reumatologia
|April 10, 2025
概括
肠道微生物组可能通过促进炎症来影响骨关节炎 (OA). 调节肠道细菌可以为这种广泛的退行性关节疾病提供一种新的治疗方法.
科学领域:
- 整形外科 整形外科 整形外科
- 微生物组研究 微生物组研究
- 免疫学 免疫学 免疫学
背景情况:
- 骨关节炎 (OA) 是一种普遍的退行性关节疾病,发病率越来越高.
- 目前的OA治疗包括NSAID,皮质类固醇,阿片类药物和手术,但挑战仍然存在.
- 新出现的证据表明,肠道微生物组 (GMB) 与OA病变发生之间存在联系.
研究的目的:
- 探索肠道微生物组在骨关节炎炎炎症过程中的潜在作用.
- 调查肠道炎症如何导致关节退化.
- 突出需要进一步研究OA的GMB调节疗法.
主要方法:
- 审查关于OA,肠道微生物组和炎症的现有文献.
- 分析将GMB失调与关节炎症联系在一起的拟议机制.
- 确定针对OA管理的GMB潜在治疗策略.
主要成果:
- 肠道炎症可以增加肠道透性,导致全身低度炎症,可能影响关节.
- 转基因细胞组合的变化与驱动OA的炎症途径有关.
- 转基因生物和OA之间的关系是复杂的,需要进一步调查.
结论:
- 肠道微生物组代表了一个有希望的,但尚未被充分探索的新型OA治疗策略的目标.
- 调节GMB可能为传统的OA治疗提供一种补充方法.
- 进一步的长期研究是必要的,以验证基于OA的GMB干预措施.
更多相关视频
08:52Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
2.9K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
147
相关概念视频
Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Inflammatory Bowel Disease II: Crohn's Disease
132
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
132
Peptic Ulcer Disease II: Pathophysiology
168
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
168
